| Concerns raised about popular blood pressure, diabetes drugs Sat, 01 Jun, 2013 07:03 AM PDT The Wall Street Journal reports that a senior FDA regulator is seeking stronger warnings about a class of blood pressure drugs that may be linked to higher cancer rates. Meanwhile, The New York Times details how a doctor hired by Merck to test a diabetes drug in rats found a possible link to pancreatic... Continue reading | |
No comments:
Post a Comment